{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:42:49Z","timestamp":1761896569416,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"DOI":"10.3389\/fnagi.2017.00210","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T06:48:27Z","timestamp":1498632507000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Cerebrospinal Fluid A\u03b243 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer\u2019s Disease, But Has Similar Diagnostic Accuracy to A\u03b242"],"prefix":"10.3389","volume":"9","author":[{"given":"Camilla","family":"Lauridsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid B.","family":"Sando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guro","family":"Berge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Precious K.","family":"Pomary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f8ril R.","family":"Gr\u00f8ntvedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d8yvind","family":"Salvesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geir","family":"Br\u00e5then","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda R.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/wnl.0000000000001859","article-title":"Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.","volume":"85","author":"Alcolea","year":"2015","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00009","article-title":"Cerebrospinal fluid levels of amyloid beta 1-43 mirror 1-42 in relation to imaging biomarkers of Alzheimer\u2019s disease.","volume":"9","author":"Almdahl","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000051246","article-title":"Cerebrospinal fluid tau levels increase with age in healthy individuals.","volume":"12","author":"Blomberg","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.neurobiolaging.2008.02.007","article-title":"CSF biomarker levels in early and late onset Alzheimer\u2019s disease.","volume":"30","author":"Bouwman","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.2174\/15672050113106660168","article-title":"The diagnostic value of CSF amyloid-beta(43) in differentiation of dementia syndromes.","volume":"10","author":"Bruggink","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jmb.2015.06.008","article-title":"C-terminal threonine reduces Abeta43 amyloidogenicity compared with Abeta42.","author":"Chemuru","year":"2016","journal-title":"J. Mol. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000441776","article-title":"Comparison between early-onset and late-onset Alzheimer\u2019s disease patients with amnestic presentation: CSF and (18)F-FDG PET study.","volume":"6","author":"Chiaravalloti","year":"2016","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"B8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3233\/jad-121927","article-title":"Amyloid deposition in early onset versus late onset Alzheimer\u2019s disease.","volume":"35","author":"Cho","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1021\/bi500131a","article-title":"The C-terminal threonine of Abeta43 nucleates toxic aggregation via structural and dynamical changes in monomers and protofibrils.","volume":"53","author":"Conicella","year":"2014","journal-title":"Biochemistry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease.","volume":"68","author":"Craig-Schapiro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.neurobiolaging.2007.08.019","article-title":"The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer\u2019s disease.","volume":"30","author":"Glodzik-Sobanska","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000337386","article-title":"Does Alzheimer\u2019s disease with early onset progress faster than with late onset? A case-control study of clinical progression and cerebrospinal fluid biomarkers.","volume":"33","author":"Gronning","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/s1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study.","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1097\/00001756-200210070-00028","article-title":"Age at onset is associated with disease severity in Lewy body variant and Alzheimer\u2019s disease.","volume":"13","author":"Ho","year":"2002","journal-title":"Neuroreport"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease.","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"B19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.14712\/fb2009055040126","article-title":"Total-tau and phospho-tau(181Thr) in cerebrospinal fluid of neurologically intact population increase with age.","volume":"55","author":"Jaworski","year":"2009","journal-title":"Folia Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3233\/jad-2009-1075","article-title":"Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer\u2019s disease and Creutzfeldt-Jakob disease.","volume":"17","author":"Jesse","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1007\/s12035-015-9358-0","article-title":"The role of PGRN in Alzheimer\u2019s disease.","volume":"53","author":"Jing","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ejhg.2010.107","article-title":"The PSEN1 I143T mutation in a Swedish family with Alzheimer\u2019s disease: clinical report and quantification of Abeta in different brain regions.","volume":"18","author":"Keller","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00030","article-title":"Cerebrospinal fluid levels of amyloid beta 1-43 in patients with amnestic mild cognitive impairment or early Alzheimer\u2019s disease: a 2-year follow-up study.","volume":"8","author":"Lauridsen","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1373\/clinchem.2014.236679","article-title":"Importance and impact of preanalytical variables on Alzheimer disease biomarker concentrations in cerebrospinal fluid.","volume":"61","author":"Le Bastard","year":"2015","journal-title":"Clin. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0891988706297086","article-title":"Early-onset Alzheimer\u2019s disease is associated with greater pathologic burden.","volume":"20","author":"Marshall","year":"2007","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3233\/jad-150746","article-title":"Progranulin protein levels in cerebrospinal fluid in primary neurodegenerative dementias.","volume":"50","author":"Morenas-Rodriguez","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/s1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/brain\/aws113","article-title":"Amyloid burden and metabolic function in early-onset Alzheimer\u2019s disease: parietal lobe involvement.","author":"Ossenkoppele","year":"2012","journal-title":"Brain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000101843","article-title":"A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia.","volume":"4","author":"Petzold","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/jad-2010-100561","article-title":"Cerebrospinal fluid markers for Alzheimer\u2019s disease over the lifespan: effects of age and the APOEepsilon4 genotype.","volume":"22","author":"Popp","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/brain\/awp326","article-title":"Increased metabolic vulnerability in early-onset Alzheimer\u2019s disease is not related to amyloid burden.","author":"Rabinovici","year":"2010","journal-title":"Brain"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nn.2858","article-title":"Potent amyloidogenicity and pathogenicity of Abeta43.","volume":"14","author":"Saito","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055847","article-title":"The pathogenic abeta43 is enriched in familial and sporadic Alzheimer disease.","volume":"8","author":"Sandebring","year":"2013","journal-title":"PLoS ONE"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1056\/NEJMoa0806142","article-title":"Age, neuropathology, and dementia.","volume":"360","author":"Savva","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamaneurol.2015.1285","article-title":"Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age.","volume":"72","author":"Sutphen","year":"2015","journal-title":"JAMA Neurol."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135886","article-title":"Levels and age dependency of neurofilament light and glial fibrillary acidic protein in healthy individuals and their relation to the brain parenchymal fraction.","volume":"10","author":"Vagberg","year":"2015","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1471-4159.2009.06170.x","article-title":"Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.","volume":"110","author":"Welander","year":"2009","journal-title":"J. Neurochem."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135458","article-title":"The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer\u2019s but not Parkinson\u2019s disease or dementia with Lewy bodies.","volume":"10","author":"Wennstrom","year":"2015","journal-title":"PLoS ONE"},{"key":"B41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2013beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.","volume":"256","author":"Winblad","year":"2004","journal-title":"J. Intern. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.ajpath.2013.01.053","article-title":"Abeta43 is the earliest-depositing Abeta species in APP transgenic mouse brain and is converted to Abeta41 by two active domains of ACE.","volume":"182","author":"Zou","year":"2013","journal-title":"Am. J. Pathol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2017.00210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T03:25:34Z","timestamp":1750389934000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnagi.2017.00210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,28]]},"references-count":42,"alternative-id":["10.3389\/fnagi.2017.00210"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2017.00210","relation":{},"ISSN":["1663-4365"],"issn-type":[{"type":"electronic","value":"1663-4365"}],"subject":[],"published":{"date-parts":[[2017,6,28]]},"article-number":"210"}}